Transcriptome-wide study of TNF-inhibitor therapy in rheumatoid arthritis reveals early signature of successful treatment

BACKGROUND: Despite the success of TNF-inhibitor therapy in rheumatoid arthritis treatment, up to 40% of patients fail to respond adequately. This study aimed to identify transcriptome-based biomarkers of adalimumab response in rheumatoid arthritis (RA) to aid timely switching in non-responder patie...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Arthritis Res Ther
Main Authors: OIiver, James, Nair, Nisha, Orozco, Gisela, Smith, Samantha, Hyrich, Kimme L., Morgan, Ann, Isaacs, John, Wilson, Anthony G., Barton, Anne, Plant, Darren
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2021
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7948368/
https://ncbi.nlm.nih.gov/pubmed/33691749
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-021-02451-9
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares